ORBIS INVESTMENT MANAGEMENT LIMITED

Company

Tempest Therapeutics, Inc.

Filed

February 16, 2016

Accession Number

0001085146-16-003198

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →